v3.26.1
Stockholders’ (Deficit) Equity (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Feb. 27, 2026
Jun. 24, 2025
Mar. 07, 2025
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Nov. 05, 2024
Nov. 04, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Aggregate value   $ 10,000,000.0            
Fair value   265,957            
Additional issuance costs   74,000            
Change in fair value of this equity payable       $ 28,171 $ (7,200)      
Purchase of shares         0      
Stock based compensation expense       55,872 $ 72,291      
Unrecognized stock-based compensation expense       $ 152,444        
Weighted average period       1 year 10 months 24 days        
common stock par value       $ 0.0001   $ 0.0001    
Gross proceeds       1,999,791      
Issuance costs       51,791        
Other costs       282,849        
March 2025 PreFunded Warrants [Member] | Private Placement [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Warrants to purchase shares     2,105,265          
Issuance costs           $ 290,317    
Placement fees           199,863    
Legal fee           64,312    
Other costs           $ 26,142    
March 2025 Common Warrants [Member] | Private Placement [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Warrants to purchase shares     2,105,265          
March 2025 Common Warrants And Prefunded Warrants [Member] | Private Placement [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Warrants to purchase shares             957,200  
Warrants exercise price     $ 0.9499     $ 1.00 $ 1.00 $ 2.06
Gross proceeds     $ 2,000,000.0          
Issuance costs     $ 53,890          
Location, Statement of Income, Balance [Axis]: us-gaap:GeneralAndAdministrativeExpense                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Stock based compensation expense       55,872 56,844      
Location, Statement of Income, Balance [Axis]: us-gaap:ResearchAndDevelopmentExpense                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Stock based compensation expense       $ 0 $ 15,447      
Securities Purchase Agreements [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Aggregate principal amount $ 1,344,000              
ELOC Shares [Member] | Equity Purchase Agreement [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Aggregate value   $ 10,000,000.0            
Warrant [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Shares issued   426,829            
Warrant Liabilities [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
common stock par value $ 0.0001              
Warrant Liabilities [Member] | Securities Purchase Agreements [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Aggregate principal amount $ 144,000              
Maturity date Feb. 27, 2031              
Warrant exercise price, description The exercise price of the Warrant Liabilities is equal to (i) 110% of the price per share paid in a Qualified Offering that occurs by the Initial Exercise Date, or (ii) 110% of the VWAP for the five-trading-day period beginning on the 181st day and ending on the 185th day after the issuance date if a Qualified Offering has not occurred by the Initial Exercise Date. The variable exercise price for the Warrants results in there being no floor for the exercise price if the exercise price is determined in the absence of a Qualified Offering, which creates the potential for an indeterminable number of shares underlying the Warrants. Accordingly, the Company was required to adopt a sequencing policy during the three months ended March 31, 2026 (see Note 3 – Summary of Significant Accounting Policies – Sequencing Policy).              
Warrant exercise price percentage 110.00%              
Percentage of voting power interest acquired in business combination 50.00%